author-photo

Shannon Dervin

Genentech

8

Papers

34

Citations

Citation Trend

Filter By

Papers (7) Sort By

Journal Conference Others

Efficacy, Safety and Biomarker Analysis of Combined PD-L1 (Atezolizumab) and VEGF (Bevacizumab) Blockade in Advanced Malignant Peritoneal Mesothelioma.

2021 Cancer Discovery
Show All
- Source
- Cite
- Save
Citations (2)
Phase I/II study to evaluate the safety and clinical efficacy of atezolizumab (atezo; aPDL1) in combination with temozolomide (TMZ) and radiation in patients with newly diagnosed glioblastoma (GBM).

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (3)
CTIM-11. PHASE I/II STUDY TO EVALUATE THE SAFETY AND CLINICAL EFFICACY OF ATEZOLIZUMAB (ATEZO) IN COMBINATION WITH TEMOZOLOMIDE (TMZ) AND RADIATION IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM)

2020 Neuro-oncology
Show All
- Source
- Cite
- Save
Citations (0)
Atezolizumab combinations with targeted therapy for anaplastic thyroid carcinoma (ATC).

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (9)
A phase II trial of atezolizumab and bevacizumab in patients with relapsed/refractory and unresectable malignant peritoneal mesothelioma.

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (2)
Safety and interim results from a phase II, single-arm study of atezolizumab and bevacizumab in Merkel cell carcinoma (MCC).

2019 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
ATIM-37. SAFETY RUN-IN RESULTS OF A PHASE I/II STUDY TO EVALUATE THE SAFETY AND CLINICAL EFFICACY OF ATEZOLIZUMAB (ATEZO; aPDL1) IN COMBINATION WITH TEMOZOLOMIDE (TMZ) AND RADIATION IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM)

2018 Neuro-oncology
Show All
- Source
- Cite
- Save
Citations (0)